WRB (Wnt1 Responsive Bone protein), also known as CHD5 (Congenital Heart Disease Protein 5), is a transmembrane receptor critical for the post-translational insertion of tail-anchored (TA) proteins into the endoplasmic reticulum (ER) membrane. Recombinant WRB refers to engineered versions of this protein produced in vitro for experimental or therapeutic purposes. It functions as part of the TRC40 pathway, collaborating with CAML (Calcium-Modulating Cyclophilin Ligand) to mediate TA protein targeting and membrane integration .
WRB forms a heterodimeric receptor complex with CAML, which is essential for TRC40-mediated TA protein insertion. Below are key findings from biochemical and structural studies:
WRB recruits TRC40 to the ER membrane, enabling TA protein delivery .
CAML stabilizes WRB, and its absence destabilizes WRB mRNA, leading to reduced protein levels .
WRB’s coiled-coil domain competitively inhibits TRC40-mediated insertion in vitro, confirming its role as a docking site .
Recombinant WRB variants have been instrumental in elucidating its function:
Expression: Purified WRBcc (fused to maltose-binding protein) was expressed in E. coli and used to study TRC40 binding .
Function: WRBcc directly binds TRC40 and blocks TA protein insertion in vitro, reducing glycosylation of substrates like HZZ-RAMP4op by up to 92% .
| TA Protein | Inhibition by WRBcc | Experimental System | Source |
|---|---|---|---|
| HZZ-RAMP4op | 92% reduction | Rough microsomes (RMs) | |
| Cytochrome b5 (Cb5) | Partial reduction | TRC40-dependent insertion |
Proteoliposomes: Recombinant WRB and CAML were reconstituted into liposomes to mimic ER membrane targeting. These liposomes supported TRC40-dependent TA protein insertion, confirming the sufficiency of WRB-CAML for this process .
Mouse models with tissue-specific WRB knockouts revealed critical dependencies:
Syntaxin 5 (Stx5) exhibited extreme sensitivity to WRB depletion, linked to its aggregation-prone cytoplasmic domain .
CAML stability depends on WRB; WRB knockout leads to CAML degradation via the proteasome .
Congenital Heart Disease: WRB is located on chromosome 21 and implicated in Down syndrome-associated heart defects .
Hearing Loss: WRB-deficient hair cells show reduced otoferlin levels, critical for mechanotransduction .